Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

Clinical trial NCT01118013 · TERMINATED

Trial details

NCT number: NCT01118013
Sponsor: Alliance for Clinical Trials in Oncology
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2010-12-01
Primary completion: 2012-03-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.